Efficacy of Methylprednisolone Pulse Followed by Oral Prednisone in Birdshot Chorioretinopathy

REFERENCES

• Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89:31–45.
   PubMed Web of Science ®Google Scholar
• Vitale AT. Birdshot retinochoroidopathy. J Ophthalmic Vis Res. 2014;9:350–361.
   PubMedGoogle Scholar
• Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50:519–541.
   PubMed Web of Science ®Google Scholar
• Llorenç Bellés V, Adán Civera A, Espinosa Garriga G, et al. [Uveitis diagnosis characterization at a referral centre in the area of Barcelona, Spain]. Med Clínica. 2012;138:277–282.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol Chic Ill 1960. 1996;114:593–599.
   PubMed Web of Science ®Google Scholar
• Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993;17:71–76.
   PubMed Web of Science ®Google Scholar
• Kuiper J, Rothova A, de Boer J, et al. The immunopathogenesis of birdshot chorioretinopathy; a bird of many feathers. Prog Retin Eye Res. 2015;44:99–110.
   PubMed Web of Science ®Google Scholar
• Kuiper JJW, Rothova A, Schellekens PAW, et al. Detection of choroid- and retina-antigen reactive CD8(+) and CD4(+) T lymphocytes in the vitreous fluid of patients with birdshot chorioretinopathy. Hum Immunol. 2014;75:570–577.
   PubMed Web of Science ®Google Scholar
• Papadia M, Herbort CP. Reappraisal of birdshot retinochoroiditis (BRC): a global approach. Graefes Arch Clin Exp Ophthalmol. 2013;251:861–869.
   PubMed Web of Science ®Google Scholar
• Papadia M, Herbort CP. Indocyanine green angiography (ICGA) is essential for the early diagnosis of birdshot chorioretinopathy. Klin Monbl Augenheilkd. 2012;229:348–352.
   PubMed Web of Science ®Google Scholar
• Chiquet C, Berthemy-Pellet S, Altayrac-Bethenod J, et al. Multifocal electroretinogram in Birdshot chorioretinopathy. Retina 2015;35:1256–1265.
   PubMed Web of Science ®Google Scholar
• Sobrin L, Lam BL, Liu M, et al. Electroretinographic monitoring in birdshot chorioretinopathy. Am J Ophthalmol. 2005;140:52–64.
   PubMed Web of Science ®Google Scholar
• Menezo V, Taylor SR. Birdshot uveitis: current and emerging treatment options. Clin Ophthalmol Auckl NZ. 2014;8:73–81.
   PubMedGoogle Scholar
• Thorne JE, Jabs DA, Peters GB, et al. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005;140:45–51.
   PubMed Web of Science ®Google Scholar
• Gass JDM. Vitiliginous chorioretinitis. 1981. Retina 2003;23:1778–1787.
   Google Scholar
• Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol. 1988;72:646–659.
   PubMed Web of Science ®Google Scholar
• Fuerst DJ, Tessler HH, Fishman GA, et al. Birdshot retinochoroidopathy. Arch Ophthalmol Chic Ill. 1960;. 1984;102:214–219.
   Google Scholar
• Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology. 1994;101:822–831.
   PubMed Web of Science ®Google Scholar
• Oh KT, Christmas NJ, Folk JC. Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. Am J Ophthalmol. 2002;133:622–629.
   PubMed Web of Science ®Google Scholar
• Kiss S, Ahmed M, Letko E, et al. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005;112:1066–1071.
   PubMed Web of Science ®Google Scholar
• Becker MD, Wertheim MS, Smith JR, et al. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression. Ocul Immunol Inflamm. 2005;13:289–293.
   PubMed Web of Science ®Google Scholar
• Knecht PB, Papadia M, Herbort CP. Early and sustained treatment modifies the phenotype of birdshot retinochoroiditis. Int Ophthalmol. 2014;34:563–574.
   PubMed Web of Science ®Google Scholar
• Levinson RD, Brezin A, Rothova A, et al. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006;141:185–187.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan C-C, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471.
   PubMed Web of Science ®Google Scholar
• Comander J, Loewenstein J, Sobrin L. Diagnostic testing and disease monitoring in birdshot chorioretinopathy. Semin Ophthalmol. 2011;26:329–336.
   PubMed Web of Science ®Google Scholar
• Rush RB, Goldstein DA, Callanan DG, et al. Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device. Am J Ophthalmol. 2011;151:630–636.
   PubMed Web of Science ®Google Scholar
• Doycheva D, Jägle H, Zierhut M, et al. Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up. Br J Ophthalmol. 2015;99:87–91.
   PubMed Web of Science ®Google Scholar
• Cervantes-Castañeda RA, Gonzalez-Gonzalez LA, Cordero-Coma M, et al. Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up. Br J Ophthalmol. 2013;97:637–643.
   PubMed Web of Science ®Google Scholar
• Ladas JG, Arnold AC, Holland GN. Control of visual symptoms in two men with birdshot retinochoroidopathy using low-dose oral corticosteroid therapy. Am J Ophthalmol. 1999;128:116–118.
   PubMed Web of Science ®Google Scholar
• Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54:3310–3318.
   PubMed Web of Science ®Google Scholar
• Fardet L. [Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica]. Rev Med Interne. 2013;34:438–443.
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, Wells AF. Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis. Rheumatology. 2014;53:1742–1751.
   Google Scholar
• Bello C, Goldstein F, Thornton JJ. Alternate-day prednisone treatment and treatment maintenance in Crohn’s disease. Am J Gastroenterol. 1991;86:460–466.
   PubMed Web of Science ®Google Scholar
• Kirwan JR, Hällgren R, Mielants H, et al. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis. Ann Rheum Dis. 2004;63:688–695.
   PubMed Web of Science ®Google Scholar
• Walsh M, Merkel PA, Mahr A, et al. The effects of duration of glucocorticoid therapy on relapse rate in anti-neutrophil cytoplasm antibody associated vasculitis: A meta-analysis. Arthritis Care Res. 2010;62:1166–1173.
   PubMed Web of Science ®Google Scholar
• Pincus T, Swearingen CJ, Luta G, et al. Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial. Ann Rheum Dis. 2009;68:1715–1720.
   Google Scholar
• Buttgereit F, Doering G, Schaeffler A, et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis. 2010;69:1275–1280.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Taylor SRJ, Lightman S. Long-term clinical and anatomic outcome of birdshot chorioretinopathy. JAMA Ophthalmol. 2014;132:57–62.
   PubMed Web of Science ®Google Scholar
• Rothova A, Ossewaarde-van Norel A, Los LI, et al. Efficacy of low-dose methotrexate treatment in birdshot chorioretinopathy. Retina 2011;31:1150–1155.
   PubMed Web of Science ®Google Scholar
• Lardenoye CWTA, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113:1446–1449.
   PubMed Web of Science ®Google Scholar
• Terrada C, Bruneau S, Perrenoud F, et al. [Role of intravitreal dexamethasone implant in the treatment of birdshot retinochoroidopathy]. J Fr Ophtalmol. 2012;35:745–748.
   PubMed Web of Science ®Google Scholar
• Bajwa A, Aziz K, Foster CS. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy. Retina. 2014;34:2259–2268.
   PubMed Web of Science ®Google Scholar
• Touhami S, Fardeau C, Vanier A, et al. Visual acuity in birdshot retinochoroidopathy evaluation. Am J Ophthalmol. 2015;160:817–821.
   PubMed Web of Science ®Google Scholar